Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too


Kosehasanogullari G., ÖZAKBAŞ S., Idiman E.

CLINICAL NEUROLOGY AND NEUROSURGERY, cilt.136, ss.107-109, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 136
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.clineuro.2015.05.030
  • Dergi Adı: CLINICAL NEUROLOGY AND NEUROSURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.107-109
  • Anahtar Kelimeler: Multiple sclerosis, Cerebrospinal fluid, Tau protein, AXONAL DEGENERATION, DIAGNOSTIC-CRITERIA, BIOLOGICAL MARKERS, CSF, DISEASE, DAMAGE, BLOOD, PROGRESSION, BIOMARKERS, DISABILITY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objectives: Axonal loss is the cause of permanent neurologic disability in patients with MS. There are a lot of candidates to be a surrogate biological marker of the axonal loss in MS including tau protein. In the present study, we aimed to assess the levels of the tau protein in patients with MS, and in neurologically healthy controls.